A number of biotech companies, including Sorrento Therapeutics Inc (NASDAQ:SRNE), have staked a lot on CAR-T therapies for cancer patients. Yesterday, Sorrento reported initial results …
Analyst spotlights a compelling commercial future ahead for Sorrento’s ZTlido in post-herpetic neuralgia.
